Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Single Antiplatelet Therapy”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Not applicableLooking for participantsNCT05785897
What this trial is testing

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

Who this might be right for
ST Elevation Myocardial Infarction
IGLESIAS Juan Fernando 350
Large-scale testing (Phase 3)Not Yet RecruitingNCT07454707
What this trial is testing

Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

Who this might be right for
Stroke, Ischemic
Sunnybrook Health Sciences Centre 1,204
Early research (Phase 1)Study completedNCT03698513
What this trial is testing

Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 113
Post-approval studies (Phase 4)Active Not RecruitingNCT03560310
What this trial is testing

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Vastra Gotaland Region 2,201
Not applicableUnknownNCT02808039
What this trial is testing

Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy With Ticagrelor - a Single Center Prospective Observational Trial

Who this might be right for
Dual Antiplatelet TherapyPlatelet Reactivity
Rabin Medical Center 60
Not applicableNot Yet RecruitingNCT07125651
What this trial is testing

Gastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.

Who this might be right for
Gastro Intestinal BleedingIschaemic Heart DiseasesAntiplatelet Drugs+1 more
Assiut University 112
Not applicableStudy completedNCT01358422
What this trial is testing

Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery

Who this might be right for
BleedingThrombosisCardiac Events
European Society of Anaesthesiology 830
Large-scale testing (Phase 3)Not Yet RecruitingNCT07818083
What this trial is testing

The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent

Who this might be right for
Ruptured Intracranial AneurysmsSubarachnoid Hemorrhage, Aneurysmal
First Affiliated Hospital of Fujian Medical University 622
Not applicableStudy completedNCT05750758
What this trial is testing

Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon Angioplasty

Who this might be right for
Acute Coronary Syndrome
Henan Institute of Cardiovascular Epidemiology 140
Post-approval studies (Phase 4)Study completedNCT01706510
What this trial is testing

Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients

Who this might be right for
Coronary Artery Disease
Rapid City Regional Hospital, Inc 28
Post-approval studies (Phase 4)Not Yet RecruitingNCT07496281
What this trial is testing

OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation

Who this might be right for
Atrial Fibrillation (AF)Coronary Artery DiseaseDrug-eluting Stent
Ewha Womans University Mokdong Hospital 2
Post-approval studies (Phase 4)Study completedNCT03431142
What this trial is testing

Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial

Who this might be right for
Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage
Shenyang Northern Hospital 7,758
Post-approval studies (Phase 4)Looking for participantsNCT06509893
What this trial is testing

Ticagrelore Alone Post PCI

Who this might be right for
Coronary Artery Disease
Shiraz University of Medical Sciences 5,400
Post-approval studies (Phase 4)Study completedNCT01962545
What this trial is testing

Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study

Who this might be right for
Atrial FibrillationCoronary Artery Disease
Satoshi Shizuta 690
Not applicableLooking for participantsNCT05650411
What this trial is testing

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

Who this might be right for
Left Main Coronary Artery Stenosis
IGLESIAS Juan Fernando 828
Large-scale testing (Phase 3)Looking for participantsNCT03789916
What this trial is testing

SAPT Versus DAPT in Incomplete Revascularization After CABG

Who this might be right for
Coronary Artery Disease
Campus Bio-Medico University 800
Not applicableLooking for participantsNCT06168370
What this trial is testing

Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation

Who this might be right for
Severe Aortic Valve Stenosis
St. Antonius Hospital 2,500
Post-approval studies (Phase 4)UnknownNCT06088433
What this trial is testing

Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease

Who this might be right for
Coronary Heart Disease
Fu Wai Hospital, Beijing, China 292
Not applicableStudy completedNCT06876727
What this trial is testing

Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair

Who this might be right for
Abdominal Aortic Aneurysms (AAA)Endovascular Aneurysm Repair (EVAR)
Samsung Medical Center 8,325
Post-approval studies (Phase 4)Looking for participantsNCT06873321
What this trial is testing

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Who this might be right for
Peripheral Arterial DiseaseVenous ThormboembolismCardiovascular Diseases+1 more
Science Valley Research Institute 100
Next Page